Research Article
The Synergistic Anticancer Effect of Dual Drug- (Cisplatin/Epigallocatechin Gallate) Loaded Gelatin Nanoparticles for Lung Cancer Treatment
Figure 6
Viability of A549 cells treated with variant cisplatin formulations on (a) day 1, (b) day 3, and (c) day 7. Group explanation: cisplatin: only cisplatin added to the medium; cisplatin+EGCG: both cisplatin and EGCG added in the medium as dual drugs; and GE-Pt: GE NPs with cisplatin loading ( compared with GE-Pt, # compared with cisplatin).
(a) |
(b) |
(c) |